Product Description
Since last many years Saintroy Lifescience is leading manufacture, export and supplier of Tamoxifen Citrate Tablets from Surat, Gujarat, India. Tamoxifen Citrate Tablets used selective estrogen receptor modulator used to prevent breast cancer in women andtreat breast cancer in women and men.
Tags: Tamoxifen Citrate Tablets manufacturer, Tamoxifen Citrate Tablets exporter, Tamoxifen Citrate Tablets supplier, Tamoxifen Citrate Tablets ,Tamoxifen Citrate potassium, whogmp approved , Tamoxifen Citrate potassium tablets manufacturer and supplier, Tamoxifen Citrate Tablets distributor, Tamoxifen Citrate Tablets drop shipper, Tamoxifen Citrate Tablets 10 mg, Tamoxifen Citrate Tablets 10 mg supplier, Tamoxifen Citrate Tablets 10 mg.
ISO/GMP/c-GMP/WHOGMP/ NAFDA Capproved, PPB Kenya approved/USFDA approved/EUGMP approved/MOH Iran approved manufacturing facility in Gujarat, India.
Registration: Saintroy Lifescience is interested in registration of own brand or customer brands in ministry of health of clients country and we also provide the products samples, COA, COPP, ACTD or CTD Dossier, DMF, Manufacturing license, Free sales certificate and other required documents.
Export Country : Saintroy Lifescience Tamoxifen Citrate Tablets exportto USA, Canada, Germany, Europe, France, Ghana, Nigeria, Kenya, Senegal, Sudan,UAE, Kuwait, Dubai, Cameroon, Lebanon, Peru, Chile, Somalia, Philippines,Myanmar, Maldives, Thailand, Singapore, Malaysia, Hong Kong, China, Zimbabwe,Togo, Burkina Faso, Niger, Guinea Bissau, Congo, Democratic of republic, IvoryCosta, Oman, Guatemala, Nicaragua, Salvador, Qatar, Costa Rica, Panama, Cuba,Colombia, Bolivia, Argentine, Algeria, Guyana, Morocco, Jordan, Bahrain, Iran,Egypt, Kyrgyzstan, Uzbekistan, Kazakhstan.
Effective Breast Cancer ManagementTamoxifen Citrate Tablets are designed to support patients in the management and prevention of hormone-receptive breast cancer. Their precise formulation ensures potency and stability, making them a reliable choice for healthcare providers and patients. As a key product distributed broadly across India, they are trusted by medical professionals and institutions alike.
Quality Manufacturing and DistributionWith rigorous quality control processes in place, Tamoxifen Citrate Tablets are manufactured reliably to maintain their physical and chemical integrity. Exported and distributed on a large scale by established dealers and suppliers in India, the tablets meet industry standards, ensuring customers receive a consistent, high-quality product each time.
FAQ's of Tamoxifen Citrate Tablets:
Q: How should Tamoxifen Citrate Tablets be stored to maintain their efficacy?
A: Tamoxifen Citrate Tablets should be stored in a cool and dry place, away from direct sunlight and moisture, to ensure their effectiveness throughout the 2-year shelf life.
Q: What is the recommended usage of Tamoxifen Citrate Tablets?
A: These tablets are primarily used as a therapeutic agent in the treatment and prevention of certain types of breast cancer. Always follow your healthcare provider's prescribed dosage and instructions for safe and effective results.
Q: When is the best time to take Tamoxifen Citrate Tablets?
A: It is generally advised to take Tamoxifen Citrate Tablets at the same time each day for optimal effect. Consult your doctor for specific timing that suits your treatment plan.
Q: Where are Tamoxifen Citrate Tablets manufactured and supplied from?
A: Tamoxifen Citrate Tablets are manufactured and supplied by certified pharmaceutical companies in India, available through dealers, distributors, exporters, suppliers, traders, and wholesalers.
Q: What is the process involved in distributing Tamoxifen Citrate Tablets in India?
A: Distribution involves stringent quality checks from manufacturing facilities, followed by careful packaging and delivery to certified dealers and suppliers across India, ensuring product authenticity and safety.
Q: What are the benefits of using Tamoxifen Citrate Tablets?
A: The primary benefit of Tamoxifen Citrate Tablets is their proven effectiveness in reducing the risk and recurrence of certain breast cancers, making them an essential component in long-term oncological treatment strategies.